POST Online Media Lite Edition



 

Roche announces change in board of directors

Staff writer |
Basel, Switzerland - September 4, 2014, Basel, Switzerland - F. Hoffmann-La Roche Ltd., a global health-care company, announced that Arthur D. Levinson has resigned from the board of directors.

Article continues below






Mr. Levinson has served as a member of the Roche Board of Directors since 2010 and served as Chairman of Genentech from 1999 to 2014. Levinson joined Genentech in 1980 as a research scientist and became Vice President, Research Technology in 1989; Vice President, Research in 1990; Senior Vice President, Research in 1992; and Senior Vice President, Research and Development in 1993.

He served as Chief Executive Officer of Genentech from 1995 to 2009. Since 2013 he has served as Chief Executive Officer of Calico, a company focusing on understanding the process of aging and developing therapies for age-related diseases.

Mr. Levinson was appointed Chairman of the Board of Apple in November 2011. He served as a co-lead director of Apple’s board since 2005 and a director since 2000. He is Chairman of the Board of Amyris and a director of NGM Biopharmaceuticals, Inc. and the Broad Institute of MIT and Harvard. He was a director of Google, Inc. from 2004 to 2009.

 LATEST MOVES FROM Switzerland 

Glencore appoints David Wormsley as director
MoonLake Immunotherapeutics appoints chairman and director
Glencore appoints Kalidas Madhavpeddi as chairman
MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO
iOnctura appoints Joanna Horobin as chair

What to read next

Franz B. Humer to leave Roche
Egalet appoints Robert Roche to board of directors
MediciNova appoints Hiroaki Shigeta to the board